Inhibition of tumor growth by agonists of growth hormone-releasing hormone.
作者信息
Kiaris Hippokratis, Chatzistamou Ioulia
机构信息
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC 29208;
Peromyscus Genetic Stock Center, University of South Carolina, Columbia, SC 29208.
出版信息
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):11876-11878. doi: 10.1073/pnas.1817342115. Epub 2018 Nov 7.
Abstract
摘要
相似文献
1
Inhibition of tumor growth by agonists of growth hormone-releasing hormone.
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):11876-11878. doi: 10.1073/pnas.1817342115. Epub 2018 Nov 7.
2
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome.
Fertil Steril. 2004 Jul;82(1):250-2. doi: 10.1016/j.fertnstert.2003.12.036.
3
Hypothalamic releasing hormones: clinical possibilities.
Hosp Pract (Off Ed). 1986 Dec 15;21(12):63-9.
4
[Releasing hormone].
Horumon To Rinsho. 1973 Nov;21(11):1073-8.
5
Gonadotropin-releasing hormone: an update review of the antagonists versus agonists.
Int J Urol. 2012 Jul;19(7):594-601. doi: 10.1111/j.1442-2042.2012.02997.x. Epub 2012 Mar 14.
6
Effects of gonadotropin-releasing hormone agonists and antagonists on luteal function.
Curr Opin Obstet Gynecol. 2007 Jun;19(3):258-65. doi: 10.1097/GCO.0b013e3281338874.
7
Morphometric and electron-microscopic analyses of the effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Arch Pathol Lab Med. 1998 May;122(5):442-6.
8
The role of gonadotropin releasing hormone in normal and pathologic endocrine processes.
Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):306-10. doi: 10.1097/MED.0b013e3281e2c9fc.
9
[Synthesis of releasing hormones].
Acta Pharm Hung. 1974 Mar;44(1):19-24.
10
Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.
Prostate. 2013 Jun;73(8):873-83. doi: 10.1002/pros.22633. Epub 2012 Dec 31.
引用本文的文献
1
Systemic Mechanisms of Ionic Regulation in Carcinogenesis.
Cancers (Basel). 2025 Jan 17;17(2):286. doi: 10.3390/cancers17020286.
2
The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders.
Rev Endocr Metab Disord. 2025 Jun;26(3):385-396. doi: 10.1007/s11154-024-09929-2. Epub 2024 Nov 26.
3
Growth hormone-releasing hormone and its analogues in health and disease.
Nat Rev Endocrinol. 2025 Mar;21(3):180-195. doi: 10.1038/s41574-024-01052-1. Epub 2024 Nov 13.
4
Growth hormone-releasing hormone and cancer.
Rev Endocr Metab Disord. 2024 Oct 18. doi: 10.1007/s11154-024-09919-4.
5
Growth Hormone-Releasing Hormone Antagonist JV-1-36 Suppresses Reactive Oxygen Species Generation in A549 Lung Cancer Cells.
Endocrines. 2022 Dec;3(4):813-820. doi: 10.3390/endocrines3040067. Epub 2022 Dec 9.
6
Growth Hormone Releasing Hormone in Endothelial Barrier Function.
Trends Endocrinol Metab. 2021 Jun;32(6):338-340. doi: 10.1016/j.tem.2021.03.001. Epub 2021 Mar 23.
7
GHRH antagonists support lung endothelial barrier function.
Tissue Barriers. 2019;7(4):1669989. doi: 10.1080/21688370.2019.1669989. Epub 2019 Oct 3.
本文引用的文献
1
Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH.
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12028-12033. doi: 10.1073/pnas.1813375115. Epub 2018 Oct 29.
2
Growth Hormone-Releasing Hormone in Diabetes.
Front Endocrinol (Lausanne). 2016 Oct 10;7:129. doi: 10.3389/fendo.2016.00129. eCollection 2016.
3
Growth Hormone-Releasing Hormone and Its Analogues: Significance for MSCs-Mediated Angiogenesis.
Stem Cells Int. 2016;2016:8737589. doi: 10.1155/2016/8737589. Epub 2016 Sep 27.
4
Agonistic analogs of growth hormone releasing hormone (GHRH) promote wound healing by stimulating the proliferation and survival of human dermal fibroblasts through ERK and AKT pathways.
Oncotarget. 2016 Aug 16;7(33):52661-52672. doi: 10.18632/oncotarget.11024.
5
Beneficial effects of growth hormone-releasing hormone agonists on rat INS-1 cells and on streptozotocin-induced NOD/SCID mice.
Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13651-6. doi: 10.1073/pnas.1518540112. Epub 2015 Oct 16.
6
New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.
Oncotarget. 2015;6(12):9728-39. doi: 10.18632/oncotarget.3303.
7
Acceleration of wound healing by growth hormone-releasing hormone and its agonists.
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18611-5. doi: 10.1073/pnas.1013942107. Epub 2010 Oct 11.
8
Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
Nat Clin Pract Endocrinol Metab. 2008 Jan;4(1):33-43. doi: 10.1038/ncpendmet0677.
9
Ligand-dependent and -independent effects of splice variant 1 of growth hormone-releasing hormone receptor.
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9512-7. doi: 10.1073/pnas.1533185100. Epub 2003 Jul 16.
10
Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis.
Trends Endocrinol Metab. 2002 Sep;13(7):299-303. doi: 10.1016/s1043-2760(02)00613-6.
Zotero 插件